Complementary and Alternaitve Medicine use Among Cancer Patients
AbstractAlthough studies have shown that the use of complementary and alternative medicine (CAM) is common among cancer patients, there was limited data regarding CAM use among cancer patients in Indonesia. The aim of this study was to identify CAM use among cancer patients. This was a descriptive study with a cross-sectional approach conducted from July to August 2019 on 65 consenting cancer patients that selected purposively. Data were collected by sociodemographic questionnaires including a question about their CAM use. Data were analyzed using descriptive statistics. Overall, 29.2% reported that they had used or were using CAM. Herbal and vitamin supplement was the most commonly used in CAM (63.16%). Because there were still very few CAM users among cancer patients, it is important that health care professionals provide information about the CAM to the patients and aware of the extent to which cancer patients are using CAM.
Authors who publish with Jurnal Keperawatan Respati Yogyakarta agree to the following terms:
- Authors retain copyright and grant Jurnal Keperawatan Respati Yogyakarta right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY that allows others to remix, adapt, build upon the work with an acknowledgment of the work's authorship and initial publication and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).